摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氯-3-甲基吡啶-N-氮氧化物 | 91668-83-6

中文名称
2-氯-3-甲基吡啶-N-氮氧化物
中文别名
——
英文名称
2-chloro-3-methylpyridine N-oxide
英文别名
2-chloro-3-methylpyridine-1-oxide;2-Chloro-3-methylpyridine 1-oxide;2-chloro-3-methyl-1-oxidopyridin-1-ium
2-氯-3-甲基吡啶-N-氮氧化物化学式
CAS
91668-83-6
化学式
C6H6ClNO
mdl
MFCD14582951
分子量
143.573
InChiKey
ZGHMADNNOPPAJO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    316.8±22.0 °C(Predicted)
  • 密度:
    1.22±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.166
  • 拓扑面积:
    25.5
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2933399090

SDS

SDS:de8a9a59de76333363f4888d5bf5a44f
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Chloro-3-methylpyridine 1-oxide
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Chloro-3-methylpyridine 1-oxide
CAS number: 91668-83-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H6ClNO
Molecular weight: 143.6

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-氯-3-甲基吡啶-N-氮氧化物三乙胺三氯氧磷氯化铵 作用下, 以 二氯甲烷 为溶剂, 反应 5.0h, 生成 2,6-二氯-3-甲基吡啶
    参考文献:
    名称:
    通过化学设计策略研究吡啶 3-取代基对 3-取代 2,6-二氯吡啶与 1-甲基哌嗪的亲核芳香取代反应中区域选择性的影响
    摘要:
    化学设计策略已用于选择 3-取代的 2,6-二氯吡啶,用于与 1-甲基哌嗪的亲核芳香取代反应。目的是研究这些反应中区域选择性对其亲脂性 (PI)、大小 (MR) 和诱导效应 (σp) 表示的吡啶 3-取代基特征的依赖性。有趣的是,区域选择性与这些参数中的任何一个都不相关,但与 Verloop 空间参数 B1 具有统计学意义,如 p 值 0.006 (R2 = 0.45) 所示。这意味着靠近吡啶环的庞大的 3-取代基诱导朝向 6-位的区域选择性。在实际合成中有用的是用羧酸3-取代基及其前体或衍生物获得的不同区域选择性。因此,以乙腈为溶剂,3-羧酸酯和3-酰胺取代基优先得到2-异构体(6-异构体的比例为9:1),而3-氰基和3-三氟甲基取代基优先得到6-异构体。异构体(2-异构体的比例为 9:1)。2,6-二氯-3-(甲氧基羰基)吡啶与 1-甲基哌嗪在 21 种不同溶剂中反应中吡啶 2 位的区域选择性
    DOI:
    10.1002/ejoc.201200978
  • 作为产物:
    参考文献:
    名称:
    Preparation and Reactions of 2-Nitropyridine-1-oxides
    摘要:
    DOI:
    10.1021/ja01570a070
点击查看最新优质反应信息

文献信息

  • 一种钌催化剂催化维生素A异构化的方法
    申请人:万华化学集团股份有限公司
    公开号:CN111004163B
    公开(公告)日:2021-12-10
    本发明提供了一种钌催化维生素A异构体转化的方法,该方法使用钌化合物作为催化剂,在助剂存在下,可以将多种生物活性较低的维生素A顺式异构体高比例地转化为高生物活性的全反式异构体,所述顺式异构体包括9‑顺式,11‑顺式和13‑顺式异构体。本发明使用的催化剂廉价易得,催化剂用量少,反应条件温和,具有反应成本低、异构化效率高等特点。
  • SUBSTITUTED AMIDE COMPOUNDS
    申请人:Pfizer Inc.
    公开号:US20140315928A1
    公开(公告)日:2014-10-23
    The present invention is directed at substituted amide compounds, pharmaceutical compositions containing such compounds and the use of such compounds to reduce plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.
    本发明涉及替代酰胺化合物,含有这种化合物的药物组合物以及利用这种化合物降低血浆脂质水平,如LDL-胆固醇和甘油三酯,并据此治疗由高水平的LDL-胆固醇和甘油三酯加重的疾病,如动脉粥样硬化和心血管疾病,在哺乳动物,包括人类中的应用。
  • Visible-Light-Promoted C2 Selective Arylation of Quinoline and Pyridine <i>N</i>-Oxides with Diaryliodonium Tetrafluoroborate
    作者:Dazhi Li、Ce Liang、Zaixing Jiang、Junzheng Zhang、Wang-Tao Zhuo、Fan-Yue Zou、Wan-Peng Wang、Guo-Lin Gao、Jinzhu Song
    DOI:10.1021/acs.joc.9b02933
    日期:2020.2.21
    visible-light-promoted C2 selective arylation of quinoline and pyridine N-oxides, with diaryliodonium tetrafluoroborate as an arylation reagent, using eosin Y as a photocatalyst for the construction of N-heterobiaryls was presented. This methodology provided an efficient way for the synthesis of 2-aryl-substituted quinoline and pyridine N-oxides. This strategy has the following advantages: specific regioselectivity
    提出了使用曙红Y作为光催化剂构建N-杂二芳基的可见光促进的喹啉和吡啶N-氧化物的C2选择性芳基化反应,并以四氟硼酸二芳基碘铵为芳基化试剂。该方法学提供了合成2-芳基取代的喹啉和吡啶N-氧化物的有效方法。该策略具有以下优点:特定区域选择性,简单的操作,良好的官能团耐受性以及在温和条件下的高到中等产量。
  • [EN] IMIDAZOPYRIDINE COMPOUND<br/>[FR] COMPOSÉ IMIDAZOPYRIDINE
    申请人:EISAI CO LTD
    公开号:WO2005103049A1
    公开(公告)日:2005-11-03
    A compound represented by the following general formula (1), or a salt or hydrate thereof: wherein R1 represents a C1-C6 alkyl group or C2-C6 alkynyl group which may be substituted, or a phenyl group which may be substituted, R2 represents a hydrogen atom or a C1-C6 alkyl group, R3 represents methyl or ethyl group, R4 represents a C1-C6 alkyl group, R5 represents a hydrogen atom, provided that a compound wherein R1 is a C1-C6 alkyl group unsubstituted or substituted with a halogen atom and R2 is a hydrogen atom is excluded.
    由以下一般式(1)表示的化合物,或其盐或水合物:其中R1代表可被取代的C1-C6烷基或C2-C6炔基,或可被取代的苯基,R2代表氢原子或C1-C6烷基,R3代表甲基或乙基基团,R4代表C1-C6烷基,R5代表氢原子,但其中R1为未取代或取代为卤素原子的C1-C6烷基,且R2为氢原子的化合物除外。
  • Antiretroviral compounds and compositions
    申请人:Uniroyal Chemical Company, Inc.
    公开号:US06498254B1
    公开(公告)日:2002-12-24
    Certain pyridine and quinoline derivatives' which inhibit replication of the retroviruses HIV-1, HIV-2 and human cytomegalovirus (HCMV) are provided. Pharmaceutical compositions useful in methods of treating or inhibiting certain retrovirus infections are described.
    提供了一些抑制逆转录病毒HIV-1、HIV-2和人类巨细胞病毒(HCMV)复制的吡啶和喹啉衍生物。描述了在治疗或抑制某些逆转录病毒感染方法中有用的药物组合物。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-